(MedPage Today) — Note that some links may require registration or subscription. MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts. If you want to share your story, please email MPT_Editorial…
After attracting criticism for admitting that she uses a GLP-1 medication to help lose weight, Janelle Rohner claimed she refunded fans who purchased her health programs. In a TikTok video shared by the wellness influencer, 37, on Sunday, April 27, Rohner responded to a fan who asked, “Have you refunded anyone yet?” in the comments … Read more
The future of the weight-loss industry is now in President Donald Trump’s hands — and pharma companies are mobilizing to ensure the craze for highly effective anti-obesity drugs keeps spreading. The Trump administration is under heavy pressure to decide how widely available the medications should be and whether Medicare should cover them. So far, it … Read more
Pharmaceutical company Eli Lilly announced promising clinical trial results this week for a daily pill to treat obesity and diabetes. Besides the good news of minimal side effects and impressive results, though, the pill has an extremely unfortunate quality: its name. The drug, which was first discovered by Chugai Pharmaceutical and licensed to Eli Lilly … Read more
by Jennifer H Hwang, DO; Neda Laiteerapong, MD; Elbert S. Huang, MD; David D. Kim, PhDJAMA Health Forum: 2025 Mar 7;6(3):e245586. doi: 10.1001/jamahealthforum.2024.5586. Published March 14, 2025 This research evaluates the cost-effectiveness of four different antiobesity medications compared to lifestyle modification alone for US adults. Using a microsimulation model, the study projected the lifetime health benefits and costs of these treatments for … Read more
The weight-loss jabs juggernaut is showing no signs of slowing down. While the medicines arrived as obesity treatments only four years ago, the number of people in the UK using the injections is expected to reach one million this year. As relatively new drugs, evidence about their effects on the body is still emerging. The … Read more
(MedPage Today) — Another benefit of GLP-1 receptor agonist (RA) use may be protection from persistent atrial fibrillation (Afib or AF) after ablation, according to a large Veterans Affairs database. New initiators of these drugs in 2015-2022…
by Michael Monostra Fact Checked by Richard Smith from Endocrine Today/Healio NewsPublished April 25, 2025 According to findings from a microsimulation model, covering obesity medications under Medicare Part D is projected to significantly increase federal spending, estimated at $47.7 billion over ten years. While these drugs may reduce healthcare costs associated with obesity-related conditions, these savings are currently not … Read more
There’s never a dull day in the world of weight-loss medication. This week brought new restrictions on compounded GLP-1 medication, the cheaper, copycat versions of brand-name drugs that telehealth companies like Hims & Hers and Noom had been offering. Other developments include news that GLP-1 pills are on the way, and that a bankruptcy filing … Read more
GLP-1 drugs like Ozempic, while effective for significant weight loss and reducing chronic disease risk, are associated with emerging side effects. Rapid weight loss can lead to ‘Ozempic mouth,’ characterized by hollowing around the mouth, deeper lines, and a prematurely aged appearance due to skin laxity.